Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PF-07261271 by Pfizer for Inflammatory Bowel Disease: Likelihood of Approval
PF-07261271 is under clinical development by Pfizer and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...